We also noted a significant increase in the M1-like to M2-like TAM ratio (defined as the ratio between CD80+ and CD206+ TAMs, Figure 1J), indicating an increased presence of anti-tumor M1-like TAMs. This evidence concerns the gene CD80 and neoplasm.